EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Lipopolysaccharide, arbiter of the gut–liver axis, modulates hepatic cell pathophysiology in alcoholism

Ki M Mak iD, Aditya C Shekhar iD

The Anatomical Record · 2025

DOI: 10.1002/ar.25562 ↗

At a glance

Übersichtsarbeit in The Anatomical Record, 2025. Written by Ki M Mak and 1 co-authors. Institution: Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Major MEDLINE topics: Lipopolysaccharides, Alcoholism, Liver, Gastrointestinal Microbiome. Cited 39 times so far (Crossref); 173 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Over the last four decades, clinical research and experimental studies have established that lipopolysaccharide (LPS)—a component of the outer membrane of gram‐negative bacteria—is a potent hepatotoxic molecule in humans and animals. Alcohol abuse is commonly associated with LPS endotoxemia. This review highlights LPS molecular structures and modes of release from bacteria, plasma LPS concentrations, induction of microbiota dysbiosis, disruption of gut epithelial barrier, and translocation of LPS into the portal circulation impacting the pathophysiology of hepatic cells via the gut‐liver axis. We describe and illustrate the portal vein circulation and its distributaries draining the gastrointestinal tract. We also elaborate on the gut‐liver axis coupled with enterohepatic circulation that represents a bidirectional communication between the gut and liver. The review also updates the data on how circulating LPS is cleared in a coordinated effort between Kupffer cells, hepatocytes, and liver sinusoidal endothelial cells. Significantly, the article reviews and updates the modes/mechanisms of action by which LPS mediates the diverse pathophysiology of Kupffer cells, hepatocytes, sinusoidal endothelial cells, and hepatic stellate cells primarily in association with alcohol consumption. Specifically, we review the intricate linkages between ethanol, microbiota dysbiosis, LPS production, gut‐liver axis, and pathophysiology of various hepatic cells. The maintenance of the gut barrier structural and functional integrity and microbiome homeostasis is essential in mitigating alcoholic liver disease and improving liver health.

Subjects

MeSH terms (MEDLINE)

LipopolysaccharidesAlcoholismLiverGastrointestinal MicrobiomeHepatocytesGastrointestinal TractHumansAnimalsKupffer CellsDysbiosis

Author keywords

ethanolgut microbiotagut‐liver axishepatic cell pathophysiologylipopolysaccharide

Substances

Lipopolysaccharides

Authors and institutions

  • Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID profiles: Ki M Mak, Aditya C Shekhar

Cite

APA

Mak, K. M., & Shekhar, A. C. (2025). Lipopolysaccharide, arbiter of the gut–liver axis, modulates hepatic cell pathophysiology in alcoholism. The Anatomical Record. https://doi.org/10.1002/ar.25562

Vancouver

Mak KM, Shekhar AC. Lipopolysaccharide, arbiter of the gut–liver axis, modulates hepatic cell pathophysiology in alcoholism. The Anatomical Record. 2025. doi:10.1002/ar.25562

BibTeX
@article{Mak2025,
  author = {Mak, Ki M and Shekhar, Aditya C},
  title = {Lipopolysaccharide, arbiter of the gut–liver axis, modulates hepatic cell pathophysiology in alcoholism},
  journal = {The Anatomical Record},
  year = {2025},
  doi = {10.1002/ar.25562}
}
Start for free →